Characterisation of an epigenetically altered CD4 + CD28 + Kir + T cell subset in autoimmune rheumatic diseases by multiparameter flow cytometry

Lupus Science and Medicine

Volumn 3, Issue 1, 2016, Pages

  Strickland, Faith M ^a   Patel, Dipak ^a,b   Khanna, Dinesh ^a   Somers, Emily ^a,c   Robida, Aaron M ^c   Pihalja, Michael ^c   Swartz, Richard ^a   Marder, Wendy ^a   Richardson, Bruce ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Autoimmune Diseases; DNA Methylation; Kir; Systemic Lupus Erythematosus; T Cells

Indexed keywords

AZACITIDINE; C REACTIVE PROTEIN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; CD70 ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ADULT; ARTICLE; CD4+ CD28+ KIR+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ACTIVITY; DNA MODIFICATION; EPIGENETICS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUPUS LIKE SYNDROME; LUPUS VULGARIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROPERITONEAL FIBROSIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE SUBPOPULATION;

EID: 84992600199     PISSN: None     EISSN: 20538790     Source Type: Journal    
DOI: 10.1136/lupus-2016-000147     Document Type: Article

References (53)

1. Palacios R, Santos J, Valdivielso P, et al. Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature. Lupus 2002;11:60-3.
2. Fox RA, Isenberg DA. Human immunodeficiency virus infection in systemic lupus erythematosus. Arthritis Rheum 1997;40:1168-72.
3. Wofsy D, Seaman WE. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 1985;161:378-91.
4. Jabs DA, Burek CL, Hu Q, et al. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell Immunol 1992;141:496-507.
5. Richardson B. Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells. Human Immunol 1986;17:456-70.
6. Patel DR, Richardson BC. Dissecting complex epigenetic alterations in human lupus. Arthritis Res Ther 2013;15:201.
7. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007;3:521-7.
8. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
9. Somers EC, Thomas SL, Smeeth L, et al. Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology 2006;17:202-17.
10. Somers EC, Thomas SL, Smeeth L, et al. Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? Am J Epidemiol 2009;169:749-55.
11. Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 2009;33:197-207.
12. Anaya JM, Gómez L, Castiblanco J. Is there a common genetic basis for autoimmune diseases? Clin Dev Immunol 2006;13:185-95.
13. Ramos PS, Criswell LA, Moser KL, et al. A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet 2011;7:e1002406.
14. Somers EC, Ganser MA, Warren JS, et al. Mercury Exposure and Antinuclear Antibodies among Females of Reproductive Age in the United States: NHANES. Environ Health Perspect 2015;123:792-8.
15. Kubo K, Yamamoto K. IgG4-related disease. Int J Rheumatic Dis 2015:1-9.
16. Urban ML, Palmisano A, Nicastro M, et al. Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach. Rev Med Interne 2015;36:15-21.
17. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
18. Seror R, Ravaud P, Bowman SJ, et al. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 2010;69:1103-9.
19. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
20. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
21. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.
22. McCune WJ, Golbus J, Zeldes W, et al. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med 1988;318:1423-31.
23. Khanna D, Denton CP. Evidence-based management of rapidly progressing systemic sclerosis. Best Pract Res Clin Rheumatol 2010;24:387-400.
24. Swartz RD. Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment. Am J Kidney Dis 2009;54:546-53.
25. Liu Y, Chen Y, Richardson B. Decreased DNA methyltransferase levels contribute to abnormal gene expression in "senescent" CD4 (+)CD28(-) T cells. Clin Immunol 2009;132:257-65.
26. Weyand CM, Brandes JC, Schmidt D, et al. Functional properties of CD4+ CD28- T cells in the aging immune system. Mech Ageing Dev 1998;102:131-47.
27. Middleton D, Gonzelez F. The extensive polymorphism of KIR genes. Immunology 2010;129:8-19.
28. Li Y, Liu Y, Strickland FM, et al. Age-dependent decreases in DNA methyltransferase levels and low transmethylation micronutrient levels synergize to promote overexpression of genes implicated in autoimmunity and acute coronary syndromes. Exp Gerontol 2010;45:312-22.
29. Liu Y, Kuick R, Hanash S, et al. DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin Immunol 2009;130:213-24.
30. Brito-Zerón P, Ramos-Casals M, Bosch X, et al. The clinical spectrum of IgG4-related disease. Autoimmun Rev 2014;13:1203-10.
31. Seror R, Bootsma H, Saraux A, et al. Defining disease activity states and clinically meaningful improvement in primary Sjogren's syndrome with EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis 2016;75(2):382-9.
32. Lu Q, Wu A, Tesmer L, et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007;179:6352-8.
33. Farrar WL, Ruscetti FW, Young HA. 5-Azacytidine treatment of a murine cytotoxic T cell line alters interferon-gamma gene induction by interleukin 2. J Immunol 1985;135:1551-4.
34. Yung RL, Quddus J, Chrisp CE, et al. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 1995;154:3025-35.
35. Li Y, Gorelik G, Strickland FM, et al. Oxidative stress, T cell DNA methylation, and lupus. Arthritis Rheumatol 2014;66:1574-82.
36. Strickland FM, Li Y, Johnson K, et al. CD4(+) T cells epigenetically modified by oxidative stress cause lupus-like autoimmunity in mice. J Autoimmun 2015;62:75-80.
37. Ahsan H. 3-Nitrotyrosine: A biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions. Hum Immunol 2013;74:1392-9.
38. Perl A. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat Rev Rheumatol 2013;9:674-86.
39. Driscoll T, Jacklyn G, Orchard J, et al. The global burden of occupationally related low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 2014;73:975-81.
40. Gorelik G, Sawalha AH, Patel D, et al. T cell PKCδ kinase inactivation induces lupus-like autoimmunity in mice. Clin Immunol 2015;158:193-203.
41. Santourlidis S, Trompeter HI, Weinhold S, et al. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J Immunol 2002;169:4253-61.
42. Basu D, Liu Y, Wu A, et al. Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells. J Immunol 2009;183:3481-7.
43. Richardson B, Epstein WV. Utility of the fluorescent antinuclear antibody test in a single patient. Ann Intern Med 1981;95:333-8.
44. Pals ST, Radaszkiewicz T, Roozendaal L, et al. Chronic progressive polyarthritis and other symptoms of collagen vascular disease induced by graft-vs-host reaction. J Immunol 1985;134:1475-82.
45. Daikeler T, Tyndall A. Autoimmunity following haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol 2007;20:349-60.
46. Minhas U, Das P, Bhatnagar A. Role of reactive intermediates in the immunopathogenesis of the pristane-induced Balb/c model of lupus. Lupus 2011;20:1421-5.
47. Satoh M, Hamilton KJ, Ajmani AK, et al. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol 1996;157:3200-6.
48. Stasiuk LM, Ghoraishian M, Elson CJ, et al. Pristane-induced arthritis is CD4+ T-cell dependent. Immunology 1997;90:81-6.
49. Leiss H, Niederreiter B, Bandur T, et al. Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation. Lupus 2013;22:778-92.
50. Odobasic D, Muljadi RC, O'Sullivan KM, et al Suppression of Autoimmunity and Renal Disease in Pristane-Induced Lupus by Myeloperoxidase. Arthritis Rheumatol 2015;67:1868-80.
51. Li J, Wu H, Huang X, et al. Clinical analysis of 56 patients with rhupus syndrome: manifestations and comparisons with systemic lupus erythematosus: a retrospective case-control study. Medicine 2014;93:e49.
52. Mosca M, Tani C, Vagnani S, et al. The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun 2014;48-49:50-2.
53. Kuo CF, Grainge MJ, Valdes AM, et al. Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families. JAMA Intern Med 2015;175:1518-26.